Winter pathogens in the UK (2025/2026)
Share
What circulates, why it gets worse, and how to stay one step ahead
Every winter the conversation about “bugs” ramps up, and with good reason. In a typical British winter the same handful of microbes reappear in clinics, schools, care homes and news bulletins: influenza viruses, respiratory syncytial virus or RSV, norovirus, and SARS-CoV-2 among them. Each of these pathogens behaves differently, but they share two important traits. First, they find it easier to spread when people are indoors and mixing closely. Second, they cause the highest risk for the very young, the very old, and people with long-term health conditions. That combination is why winter can feel like a repeat of the year before, except sometimes worse.
The usual suspects and how they behave
Influenza. Flu viruses mutate and shift from season to season. Most healthy adults will cope with flu with a week or so of misery, but occasionally a season is driven by a strain that causes much higher numbers of hospital admissions. The UK keeps a close watch on which strains are circulating, and annual flu vaccination remains the most reliable protection for people in risk groups and for the population at large.
Respiratory syncytial virus or RSV. Historically thought of as a childhood problem, RSV also causes serious illness in older adults. The pattern changed noticeably in recent years when wide reopenings after the pandemic and varying levels of immunity created unexpected timing and sizes of RSV waves. In 2024 the UK started vaccination and prevention programmes aimed at those most at risk, including older adults and pregnant women, and uptake is monitored as part of routine surveillance.
SARS-CoV-2. COVID-19 remains part of the respiratory virus mix, though its severity at the population level has shifted thanks to vaccines and prior infection. Variants appear from time to time, and this virus contributes to winter healthcare pressure when it spikes. Public health surveillance keeps a running tally of hospital admissions and deaths linked to COVID-19 alongside other respiratory illnesses.
Norovirus. Known as the winter vomiting bug, norovirus is not a respiratory virus. It causes explosive outbreaks of vomiting and diarrhoea in closed settings such as hospitals, care homes and cruise ships. The organism is extremely contagious, survives on surfaces, and resists many common disinfectants. Outbreaks can force ward closures and visitor restrictions, adding a different type of pressure to the health system.
Why winter helps pathogens
There are biological and behavioural explanations working in tandem.
On the biological side, cold dry air affects mucus membranes and can make the respiratory tract more vulnerable to infection. Some viruses also survive longer in low humidity and lower temperatures. Behaviour matters more for the spread. Shorter daylight hours and poor weather push people indoors where ventilation is often poor. The simple act of being in crowded indoor spaces, together with seasonal reductions in vitamin D for some people, increases the chance of transmission. The upshot is that viruses which may be manageable in isolation can cascade through schools, workplaces and care settings when conditions are right.
How surveillance helps us spot trouble early
The UK operates a layered surveillance system that draws on laboratory testing, primary care reports, hospital admissions and mortality data. These multiple streams create a national picture that public health bodies use to guide vaccine campaigns, hospital preparedness and public advice. In recent seasons the surveillance reports have shown variable patterns: some winters dominated by flu, others with big RSV or localized norovirus outbreaks. That variability is why public health agencies publish weekly surveillance reports through autumn and winter.
Vaccines, treatments and what works
Vaccines remain the most effective public health tool for reducing severe disease from influenza, COVID-19 and now RSV in groups eligible for vaccination. The composition of the influenza vaccine is updated each year to match expected circulating strains. COVID-19 booster programmes and targeted RSV vaccination for vulnerable groups aim to reduce hospital admissions and deaths. Antiviral drugs exist for flu and for COVID-19 in certain cases, but they work best when given early and are not a substitute for prevention. Where norovirus is concerned, behavioural measures and rigorous infection control are the main defence because a vaccine is not widely available for routine use.
The strain on health services
When several pathogens rise at the same time the pressure on the NHS increases dramatically. Recent winters have shown how a rise in flu combined with RSV, norovirus and background COVID-19 can create what commentators called a quad-demic. The practical effects are straightforward and serious: more people in hospital beds, more staff off sick or redeployed, and more wards closed to visitors to control outbreaks. That is why vaccination campaigns, appropriate use of antivirals, and sensible infection control in hospitals and care homes are not abstract policy items but real levers to protect service capacity.
Practical steps for individuals and households
If you want to reduce the chances that winter leaves you or someone you care for poorly, there are evidence-based, pragmatic steps you can take.
Get vaccinated if you are eligible. This includes flu, COVID-19 boosters when recommended, and RSV vaccines or monoclonal antibody programmes if you are in an eligible group. Vaccines reduce the risk of severe disease and help lower the overall strain on services.
Use good respiratory hygiene. Cover coughs and sneezes, dispose of tissues promptly, and wash hands regularly with soap and water. Alcohol hand sanitiser is useful when soap and water are not available. For norovirus, handwashing with soap and water is especially important because alcohol gels are less effective against this virus.
Improve ventilation where possible. Opening windows for short periods, using extractor fans in kitchens and bathrooms and avoiding stagnant indoor air reduces the concentration of airborne virus particles. Even modest ventilation changes can reduce risk in shared spaces.
Stay home when ill and follow NHS advice. If you or a dependent are unwell with severe symptoms such as difficulty breathing, persistent high fever, confusion, or severe dehydration from vomiting and diarrhoea, seek medical help promptly. For milder illness, the NHS provides guidance on self-care and why it is better to avoid visiting vulnerable family members until symptoms have cleared.
What employers, schools and care settings should do
Employers should support staff to stay home when sick by offering sick pay and by normalising responsible behaviour. Schools and early years settings can minimise spread through handwashing routines, prompt exclusion of those with vomiting and diarrhoea until 48 hours clear, and sensible use of outdoor time where possible. Care homes need rigorous admission screening, staff vaccination, and immediate outbreak control measures including enhanced cleaning and visitor guidance.
Disinfection
It’s important to use powerful biosecurity solutions in controlling the spread of pathogens. Two of the most reliable broad-spectrum disinfectants and sterilants used in UK clinical, laboratory and public health settings are Rely+On® Virkon® and Rely+On® PeraSafe®. Both are recognised for their strong performance against a wide range of winter pathogens.
Rely+On® Virkon® is effective against numerous enveloped and non-enveloped viruses, including influenza viruses, RSV, SARS CoV 2 and norovirus. Its spectrum also covers a variety of bacteria and fungi, which makes it valuable during seasons when multiple pathogens circulate at once. It remains effective in the presence of organic material and maintains high virucidal activity across a wide environmental range, which is why it is used so widely for environmental disinfection.
Rely+On® PeraSafe® provides an even broader spectrum, with proven effectiveness against viruses, bacteria, fungi and highly resilient organisms such as bacterial spores. Its activity includes strong efficacy against non-enveloped viruses, which are typically more resistant to chemical disinfectants. This level of performance makes it suitable for situations that require high level disinfection where a broad and reliable margin of microbial elimination is essential.
Together, these products offer strong reassurance during winter, when surfaces and equipment can carry a mixture of respiratory and gastrointestinal pathogens. Their ability to inactivate a wide array of organisms supports infection control in environments where reducing environmental contamination is a priority. It’s also useful to know that these solutions can also be used in the home, offering the highest levels of protection even in domestic settings.
Looking ahead and living with winter pathogens
We are unlikely to eradicate seasonal winter pathogens. The goal is to reduce severe disease, to protect the most vulnerable, and to avoid preventable pressure on health services. That requires a mix of personal responsibility, better vaccination coverage, strong surveillance and sensible public health messaging. For readers, the takeaway is simple: vaccination if eligible, good hygiene, attention to ventilation, and seeking medical advice early if symptoms point to a serious infection.
Winter will always be a time when microbes test our systems. The tools to blunt their impact now work better than they did a decade ago. Using them consistently keeps more people out of hospital and makes winter more bearable for everyone.
Sources and links
The main references used while writing this article are below. I have focused on UK public health bodies and mainstream reporting to ensure the information is current and directly relevant.
UK Health Security Agency blog, What winter bug do I have? Know the signs and symptoms.
https://ukhsa.blog.gov.uk/2024/12/18/what-winter-bug-do-i-have-know-the-signs-and-symptoms/
UK government: National flu and COVID-19 surveillance report: 27 November 2025 (week 48).
UK government: Surveillance of respiratory syncytial virus: winter 2024 to 2025.
NHS England: Hospitals managing record flu levels going into Winter.
https://www.england.nhs.uk/2024/12/hospitals-managing-record-flu-levels-going-into-winter/
UKHSA: Weekly winter surveillance bulletin (news and updates page).
https://www.gov.uk/government/news/ukhsa-weekly-winter-surveillance-bulletin
The Guardian: Warning of NHS ‘quad-demic’ as flu and Covid cases rise in England.
